{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:31:21Z","timestamp":1790753481212,"version":"4.1.0"},"reference-count":283,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01HL139641"],"award-info":[{"award-number":["1R01HL139641"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01HL141513"],"award-info":[{"award-number":["1R01HL141513"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1UL1TR001430"],"award-info":[{"award-number":["1UL1TR001430"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013455","name":"Aniara Diagnostica","doi-asserted-by":"publisher","award":["2020-2021"],"award-info":[{"award-number":["2020-2021"]}],"id":[{"id":"10.13039\/100013455","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018578","name":"Clinical and Translational Science Institute, Boston University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018578","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["BO3482\/3-3"],"award-info":[{"award-number":["BO3482\/3-3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["BO3482\/4-1"],"award-info":[{"award-number":["BO3482\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.thromres.2022.09.025","type":"journal-article","created":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T02:15:50Z","timestamp":1664590550000},"page":"35-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Tissue factor in COVID-19-associated coagulopathy"],"prefix":"10.1016","volume":"220","author":[{"given":"Saravanan","family":"Subramaniam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hema","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Bosmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.thromres.2022.09.025_bb0005","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10735-020-09915-3","article-title":"COVID-19 and multiorgan failure: a narrative review on potential mechanisms","volume":"51","author":"Mokhtari","year":"2020","journal-title":"J. Mol. Histol."},{"issue":"8","key":"10.1016\/j.thromres.2022.09.025_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2020.100618","article-title":"COVID-19 and multiorgan response","volume":"45","author":"Zaim","year":"2020","journal-title":"Curr. Probl. Cardiol."},{"issue":"9","key":"10.1016\/j.thromres.2022.09.025_bb0015","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/jth.15041","article-title":"2020 - year of COVID-19","volume":"18","author":"Lillicrap","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-021-00264-3","article-title":"Trauma-induced coagulopathy","volume":"7","author":"Moore","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/ACO.0000000000000163","article-title":"The coagulopathy of acute sepsis","volume":"28","author":"Simmons","year":"2015","journal-title":"Curr. Opin. Anaesthesiol."},{"issue":"8","key":"10.1016\/j.thromres.2022.09.025_bb0030","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/jama.2020.13372","article-title":"Thrombosis in hospitalized patients with COVID-19 in a New York City health system","volume":"324","author":"Bilaloglu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2022.09.025_bb0035","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.thromres.2020.05.039","article-title":"Thrombosis risk associated with COVID-19 infection.A scoping review","volume":"192","author":"Al-Ani","year":"2020","journal-title":"Thromb. Res."},{"issue":"12","key":"10.1016\/j.thromres.2022.09.025_bb0040","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1182\/bloodadvances.2020002197","article-title":"COVID-19 coagulopathy vs disseminated intravascular coagulation","volume":"4","author":"Levi","year":"2020","journal-title":"Blood Adv."},{"issue":"5","key":"10.1016\/j.thromres.2022.09.025_bb0045","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.3324\/haematol.2020.262634","article-title":"Hemostatic alterations in COVID-19","volume":"106","author":"Peyvandi","year":"2021","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb0050","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb0055","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s11239-020-02275-5","article-title":"Dynamic changes in fibrinogen and D-dimer levels in COVID-19 patients on nafamostat mesylate","volume":"51","author":"Osawa","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"issue":"7","key":"10.1016\/j.thromres.2022.09.025_bb0060","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1515\/cclm-2020-0502","article-title":"COVID-19: progression of disease and intravascular coagulation - present status and future perspectives","volume":"58","author":"Harenberg","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000512007","article-title":"The impact of COVID-19 disease on platelets and coagulation","volume":"88","author":"Wool","year":"2021","journal-title":"Pathobiology"},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11739-020-02601-y","article-title":"COVID-19 coagulopathy: is it disseminated intravascular coagulation?","volume":"16","author":"Levi","year":"2021","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.thromres.2022.09.025_bb0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","article-title":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis","volume":"506","author":"Lippi","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"7","key":"10.1016\/j.thromres.2022.09.025_bb0080","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/jth.14872","article-title":"Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19","volume":"18","author":"Whyte","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb0085","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00271-13","article-title":"Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury","volume":"4","author":"Gralinski","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.thromres.2022.09.025_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100731","article-title":"Understanding the andromeda strain - the role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness","volume":"45","author":"Mir","year":"2021","journal-title":"Blood Rev."},{"issue":"11","key":"10.1016\/j.thromres.2022.09.025_bb0095","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.numecd.2020.07.040","article-title":"Association between antithrombin and mortality in patients with COVID-19.A possible link with obesity","volume":"30","author":"Gazzaruso","year":"2020","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb0100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2022.09.025_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl. Res."},{"key":"10.1016\/j.thromres.2022.09.025_bb0110","article-title":"Venous thromboembolism in the era of COVID-19","volume":"268355520955083","author":"Kyriakoulis","year":"2020","journal-title":"Phlebology"},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb0115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10557-020-07084-9","article-title":"Thrombotic complications in patients with COVID-19: pathophysiological mechanisms, diagnosis, and treatment","volume":"35","author":"Gasecka","year":"2021","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.thromres.2022.09.025_bb0120","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.thromres.2020.08.043","article-title":"Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-xa activity","volume":"196","author":"Torres-Machorro","year":"2020","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb0125","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M20-2003","article-title":"Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study","volume":"173","author":"Wichmann","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"9","key":"10.1016\/j.thromres.2022.09.025_bb0130","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1111\/jth.15004","article-title":"ISTH DIC subcommittee communication on anticoagulation in COVID-19","volume":"18","author":"Thachil","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb0135","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood.2020006520","article-title":"COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection","volume":"136","author":"Al-Samkari","year":"2020","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb0140","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1182\/blood.2020007335","article-title":"COVID-19 coagulopathy, thrombosis, and bleeding","volume":"136","author":"Chan","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0145","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/s41598-020-80010-z","article-title":"Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients","volume":"11","author":"Zuo","year":"2021","journal-title":"Sci. Rep."},{"issue":"23","key":"10.1016\/j.thromres.2022.09.025_bb0150","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2022.09.025_bb0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.thromres.2021.12.002","article-title":"SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia","volume":"209","author":"Liu","year":"2022","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb0160","first-page":"355","article-title":"Addressing vaccine-induced immune thrombotic thrombocytopenia (VITT) following COVID-19 vaccination: a mini-review of practical strategies","volume":"37","author":"Chen","year":"2021","journal-title":"Acta Cardiol. Sin."},{"key":"10.1016\/j.thromres.2022.09.025_bb0165","series-title":"Coronavirus (COVID-19) Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT)","author":"Aleem","year":"2022"},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb0170","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/ATVBAHA.117.309846","article-title":"Tissue factor: an essential mediator of hemostasis and trigger of thrombosis","volume":"38","author":"Grover","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0175","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0049-3848(87)90349-5","article-title":"Cloning and expression of human tissue factor cDNA","volume":"48","author":"Fisher","year":"1987","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0180","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0092-8674(87)90669-6","article-title":"Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade","volume":"50","author":"Morrissey","year":"1987","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.thromres.2022.09.025_bb0185","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1021\/bi00391a004","article-title":"Human tissue factor: cDNA sequence and chromosome localization of the gene","volume":"26","author":"Scarpati","year":"1987","journal-title":"Biochemistry"},{"issue":"15","key":"10.1016\/j.thromres.2022.09.025_bb0190","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1073\/pnas.84.15.5148","article-title":"Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA","volume":"84","author":"Spicer","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb0195","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1021\/bi00430a050","article-title":"Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade","volume":"28","author":"Mackman","year":"1989","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.thromres.2022.09.025_bb0200","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1182\/blood.V88.5.1583.1583","article-title":"Targeted disruption of the murine tissue factor gene results in embryonic lethality","volume":"88","author":"Toomey","year":"1996","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.thromres.2022.09.025_bb0205","doi-asserted-by":"crossref","first-page":"6258","DOI":"10.1073\/pnas.93.13.6258","article-title":"Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation","volume":"93","author":"Bugge","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6595","key":"10.1016\/j.thromres.2022.09.025_bb0210","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/383073a0","article-title":"Role of tissue factor in embryonic blood vessel development","volume":"383","author":"Carmeliet","year":"1996","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.thromres.2022.09.025_bb0215","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1172\/JCI9458","article-title":"Mouse embryogenesis requires the tissue factor extracellular domain but not the cytoplasmic domain","volume":"105","author":"Parry","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.thromres.2022.09.025_bb0220","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1111\/jth.12407","article-title":"Tissue factor purified from different cellular sources and non-glycosylated tissue factor show similar procoagulant activity","volume":"11","author":"Kothari","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"Suppl 1","key":"10.1016\/j.thromres.2022.09.025_bb0225","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.thromres.2010.01.042","article-title":"Cellular sources of tissue factor in endotoxemia and sepsis","volume":"125","author":"Pawlinski","year":"2010","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-2006-933336","article-title":"Sources of tissue factor","volume":"32","author":"Osterud","year":"2006","journal-title":"Semin. Thromb. Hemost."},{"issue":"8","key":"10.1016\/j.thromres.2022.09.025_bb0235","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1055\/s-0030-1267040","article-title":"Tissue factor and its measurement in whole blood, plasma, and microparticles","volume":"36","author":"Key","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"issue":"6","key":"10.1016\/j.thromres.2022.09.025_bb0240","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/01.ATV.0000130465.23430.74","article-title":"Role of tissue factor in hemostasis, thrombosis, and vascular development","volume":"24","author":"Mackman","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.thromres.2022.09.025_bb0245","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1016\/S0021-9258(18)42907-9","article-title":"The evaluation of complex-dependent alterations in human factor VIIa","volume":"267","author":"Lawson","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb0250","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3109\/10409238.2015.1050550","article-title":"How it all starts: initiation of the clotting cascade","volume":"50","author":"Smith","year":"2015","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"5","key":"10.1016\/j.thromres.2022.09.025_bb0255","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1213\/ane.0b013e31819bceb1","article-title":"The role of tissue factor and factor VIIa in hemostasis","volume":"108","author":"Mackman","year":"2009","journal-title":"Anesth. Analg."},{"issue":"6","key":"10.1016\/j.thromres.2022.09.025_bb0260","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1538-7836.2007.02435.x","article-title":"The tissue factor-factor VIIa complex: procoagulant activity, regulation, and multitasking","volume":"5","author":"Monroe","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"Suppl 2","key":"10.1016\/j.thromres.2022.09.025_bb0265","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.thromres.2012.02.021","article-title":"Tissue factor encryption and decryption: facts and controversies","volume":"129","author":"Rao","year":"2012","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb0270","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nm841","article-title":"Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein","volume":"9","author":"Bogdanov","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.thromres.2022.09.025_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2017.05.028","article-title":"Interplay between alternatively spliced tissue factor and full length tissue factor in modulating coagulant activity of endothelial cells","volume":"156","author":"Unlu","year":"2017","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.thromres.2022.09.025_bb0280","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tcm.2006.03.005","article-title":"Alternatively spliced tissue factor: a previously unknown piece in the puzzle of hemostasis","volume":"16","author":"Szotowski","year":"2006","journal-title":"Trends Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0285","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0008-6363(02)00857-X","article-title":"Infection and inflammation and the coagulation system","volume":"60","author":"Levi","year":"2003","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.thromres.2022.09.025_bb0290","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/jmv.23354","article-title":"Review: viral infections and mechanisms of thrombosis and bleeding","volume":"84","author":"Goeijenbier","year":"2012","journal-title":"J. Med. Virol."},{"issue":"2 Pt 1","key":"10.1016\/j.thromres.2022.09.025_bb0295","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1164\/ajrccm.161.2.9712038","article-title":"Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia.Comparison with the acute respiratory distress syndrome","volume":"161","author":"Gunther","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb0300","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/thorax.2003.013888","article-title":"Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia","volume":"59","author":"Schultz","year":"2004","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb0305","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/00000542-200610000-00013","article-title":"Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents alveolar coagulation in patients without lung injury","volume":"105","author":"Choi","year":"2006","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb0310","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11239-020-02172-x","article-title":"Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19","volume":"50","author":"Bautista-Vargas","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0315","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001337","article-title":"Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase","volume":"7","author":"DiNicolantonio","year":"2020","journal-title":"Open Heart"},{"issue":"9","key":"10.1016\/j.thromres.2022.09.025_bb0320","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1161\/ATVBAHA.120.314514","article-title":"Coagulation abnormalities and thrombosis in patients infected with SARS-CoV-2 and other pandemic viruses","volume":"40","author":"Mackman","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.thromres.2022.09.025_bb0325","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/jth.12272","article-title":"Analysis of tissue factor expression in various cell model systems: cryptic vs. active","volume":"11","author":"Kothari","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.09.025_bb0330","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2741\/4633","article-title":"Procoagulant activity during viral infections","volume":"23","author":"Subramaniam","year":"2018","journal-title":"Front. Biosci. (Landmark Ed.)"},{"issue":"5","key":"10.1016\/j.thromres.2022.09.025_bb0335","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1128\/IAI.69.5.2797-2807.2001","article-title":"Monocytes augment bacterial species- and strain-dependent induction of tissue factor activity in bacterium-infected human vascular endothelial cells","volume":"69","author":"Veltrop","year":"2001","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.thromres.2022.09.025_bb0340","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1128\/IAI.70.6.3033-3039.2002","article-title":"Peptidoglycan from Staphylococcus aureus induces tissue factor expression and procoagulant activity in human monocytes","volume":"70","author":"Mattsson","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.thromres.2022.09.025_bb0345","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.thromres.2016.11.007","article-title":"Coagulation and sepsis","volume":"149","author":"Levi","year":"2017","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb0350","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jvsv.2018.08.010","article-title":"Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients","volume":"7","author":"Obi","year":"2019","journal-title":"J. Vasc. Surg. Venous Lymphat. Disord."},{"issue":"6","key":"10.1016\/j.thromres.2022.09.025_bb0355","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/jth.13307","article-title":"Tissue factor deficiency increases alveolar hemorrhage and death in influenza A virus-infected mice","volume":"14","author":"Antoniak","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2022.09.025_bb0360","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1172\/JCI116529","article-title":"Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock","volume":"91","author":"Creasey","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb0365","first-page":"127","article-title":"Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody","volume":"33","author":"Taylor","year":"1991","journal-title":"Circ. Shock."},{"issue":"5","key":"10.1016\/j.thromres.2022.09.025_bb0370","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1182\/blood.V91.5.1609","article-title":"Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli","volume":"91","author":"Taylor","year":"1998","journal-title":"Blood"},{"issue":"9400","key":"10.1016\/j.thromres.2022.09.025_bb0375","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(03)15012-X","article-title":"Treatment of ebola virus infection with a recombinant inhibitor of factor VIIa\/tissue factor: a study in rhesus monkeys","volume":"362","author":"Geisbert","year":"2003","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.thromres.2022.09.025_bb0380","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.1073\/pnas.87.18.7095","article-title":"Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression","volume":"87","author":"Key","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.thromres.2022.09.025_bb0385","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1160\/TH07-08-0483","article-title":"Crosstalk between coagulation and inflammation during dengue virus infection","volume":"99","author":"Huerta-Zepeda","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2022.09.025_bb0390","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1093\/infdis\/jiz597","article-title":"Circulating extracellular vesicle tissue factor activity during orthohantavirus infection is associated with intravascular coagulation","volume":"222","author":"Schmedes","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.thromres.2022.09.025_bb0395","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fmicb.2015.00220","article-title":"Effect of Puumala hantavirus infection on human umbilical vein endothelial cell hemostatic function: platelet interactions, increased tissue factor expression and fibrinolysis regulator release","volume":"6","author":"Goeijenbier","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.thromres.2022.09.025_bb0400","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3389\/fmicb.2019.00817","article-title":"Zika virus infection induces elevation of tissue factor production and apoptosis on human umbilical vein endothelial cells","volume":"10","author":"Anfasa","year":"2019","journal-title":"Front. Microbiol."},{"issue":"10","key":"10.1016\/j.thromres.2022.09.025_bb0405","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1046\/j.1365-2362.2002.01041.x","article-title":"Procoagulant and inflammatory response of virus-infected monocytes","volume":"32","author":"Bouwman","year":"2002","journal-title":"Eur. J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.thromres.2022.09.025_bb0410","first-page":"251","article-title":"Cytomegalovirus-associated thrombosis","volume":"76","author":"Neppelenbroek","year":"2018","journal-title":"Neth. J. Med."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb0415","first-page":"319","article-title":"Procoagulant activity of endothelial cells after infection with respiratory viruses","volume":"84","author":"Visseren","year":"2000","journal-title":"Thromb. Haemost."},{"issue":"Pt 11","key":"10.1016\/j.thromres.2022.09.025_bb0420","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1099\/0022-1317-75-11-2863","article-title":"Measles virus induction of human endothelial cell tissue factor procoagulant activity in vitro","volume":"75","author":"Mazure","year":"1994","journal-title":"J. Gen. Virol."},{"issue":"7","key":"10.1016\/j.thromres.2022.09.025_bb0425","doi-asserted-by":"crossref","first-page":"e574","DOI":"10.1097\/CCM.0000000000001584","article-title":"Microvesicle tissue factor activity and Interleukin-8 levels are associated with mortality in patients with influenza A\/H1N1 infection","volume":"44","author":"Rondina","year":"2016","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.thromres.2022.09.025_bb0430","series-title":"Higher Tissue Factor (TF) Expression in the Lungs of COVID-19 Pneumonia Patients Than Patients With Acute Respiratory Distress Syndrome: Association With Thrombi Formation, American Society of Hematology","first-page":"4","author":"Subrahmanian","year":"2020"},{"issue":"9","key":"10.1016\/j.thromres.2022.09.025_bb0435","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1111\/jth.15451","article-title":"Tissue factor upregulation is associated with SARS-CoV-2 in the lungs of COVID-19 patients","volume":"19","author":"Subrahmanian","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.09.025_bb0440","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64330","article-title":"SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung","volume":"10","author":"Mast","year":"2021","journal-title":"elife"},{"issue":"11","key":"10.1016\/j.thromres.2022.09.025_bb0445","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood.2020007252","article-title":"Platelet activation and platelet-monocyte aggregates formation trigger tissue factor expression in severe COVID-19 patients","volume":"136","author":"Hottz","year":"2020","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.thromres.2022.09.025_bb0450","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood.2020007252","article-title":"Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19","volume":"136","author":"Hottz","year":"2020","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb0455","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood.2021010685","article-title":"SARS-CoV-2 infection induces the activation of tissue factor-mediated coagulation via activation of acid sphingomyelinase","volume":"138","author":"Wang","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.09.025_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103378","article-title":"Clinical features and prognostic factors in Covid-19: a prospective cohort study","volume":"67","author":"de Bruin","year":"2021","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.thromres.2022.09.025_bb0465","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1165\/rcmb.2020-0453OC","article-title":"Lung epithelial cell transcriptional regulation as a factor in COVID-19 associated coagulopathies","volume":"64","author":"FitzGerald","year":"2021","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"6","key":"10.1016\/j.thromres.2022.09.025_bb0470","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03185-20","article-title":"Recombinant ACE2 expression is required for SARS-CoV-2 to infect primary human endothelial cells and induce inflammatory and procoagulative responses","volume":"11","author":"Nascimento Conde","year":"2020","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.thromres.2022.09.025_bb0475","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2113874119","article-title":"Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells","volume":"119","author":"Amraei","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl 1","key":"10.1016\/j.thromres.2022.09.025_bb0480","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.thromres.2014.03.010","article-title":"The procoagulant envelope virus surface: contribution to enhanced infection","volume":"133","author":"Pryzdial","year":"2014","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb0485","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/jth.14389","article-title":"Virus envelope tissue factor promotes infection in mice","volume":"17","author":"Sutherland","year":"2019","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0490","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12985-019-1182-0","article-title":"Coronavirus envelope protein: current knowledge","volume":"16","author":"Schoeman","year":"2019","journal-title":"Virol. J."},{"issue":"17","key":"10.1016\/j.thromres.2022.09.025_bb0495","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1182\/blood-2013-09-526277","article-title":"Multiple roles of the coagulation protease cascade during virus infection","volume":"123","author":"Antoniak","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb0500","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/rth2.12109","article-title":"The coagulation system in host defense","volume":"2","author":"Antoniak","year":"2018","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.09.025_bb0505","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.3389\/fimmu.2019.02569","article-title":"Understanding infection-induced thrombosis: lessons learned from animal models","volume":"10","author":"Beristain-Covarrubias","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.thromres.2022.09.025_bb0510","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.3389\/fmicb.2019.02314","article-title":"Factors affecting the tissue damaging consequences of viral infections","volume":"10","author":"Sumbria","year":"2019","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.thromres.2022.09.025_bb0515","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1002\/jmv.26826","article-title":"Role of toll-like receptors in the pathogenesis of COVID-19","volume":"93","author":"Khanmohammadi","year":"2021","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb0520","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0378-3782(96)01734-3","article-title":"An analysis of sudden infant death syndrome in aboriginal infants","volume":"45","author":"Alessandri","year":"1996","journal-title":"Early Hum. Dev."},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb0525","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1182\/blood-2008-02-137901","article-title":"A key role for toll-like receptor-3 in disrupting the hemostasis balance on endothelial cells","volume":"113","author":"Shibamiya","year":"2009","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1016\/j.thromres.2022.09.025_bb0530","first-page":"1","article-title":"Thrombin-PAR1\/2 signaling axis modulates TLR3-mediated procoagulant, proinflammatory, and proadhesive responses in vascular endothelial cells","volume":"4","author":"Subramaniam","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"13","key":"10.1016\/j.thromres.2022.09.025_bb0535","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1182\/bloodadvances.2021004360","article-title":"A thrombin-PAR1\/2 feedback loop amplifies thromboinflammatory endothelial responses to the viral RNA analogue poly(I:C)","volume":"5","author":"Subramaniam","year":"2021","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.thromres.2022.09.025_bb0540","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/S0002-9440(10)63592-4","article-title":"Pathogenesis of ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells","volume":"163","author":"Geisbert","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.thromres.2022.09.025_bb0545","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1086\/379724","article-title":"Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes\/macrophages is a key event","volume":"188","author":"Geisbert","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb0550","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1182\/blood-2009-03-210179","article-title":"Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation","volume":"115","author":"Funderburg","year":"2010","journal-title":"Blood"},{"issue":"10234","key":"10.1016\/j.thromres.2022.09.025_bb0555","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0560","doi-asserted-by":"crossref","first-page":"W15","DOI":"10.2214\/AJR.20.23185","article-title":"Vascular changes detected with thoracic CT in coronavirus disease (COVID-19) might be significant determinants for accurate diagnosis and optimal patient management","volume":"215","author":"Qanadli","year":"2020","journal-title":"AJR Am. J. Roentgenol."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb0565","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1128\/MCB.15.2.824","article-title":"CalpA, a drosophila calpain homolog specifically expressed in a small set of nerve, midgut, and blood cells","volume":"15","author":"Theopold","year":"1995","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0570","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","volume":"136","author":"Wong","year":"2004","journal-title":"Clin. Exp. Immunol."},{"issue":"4\u20135","key":"10.1016\/j.thromres.2022.09.025_bb0575","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.micinf.2020.04.009","article-title":"Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7\/8 in the SARS-CoV-2,SARS-CoV, and MERS-CoV genomes","volume":"22","author":"Moreno-Eutimio","year":"2020","journal-title":"Microbes Infect."},{"issue":"10","key":"10.1016\/j.thromres.2022.09.025_bb0580","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/jmv.25987","article-title":"In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs","volume":"92","author":"Choudhury","year":"2020","journal-title":"J. Med. Virol."},{"issue":"38","key":"10.1016\/j.thromres.2022.09.025_bb0585","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2020.35.e343","article-title":"COVID-19 patients upregulate toll-like receptor 4-mediated inflammatory signaling that mimics bacterial sepsis","volume":"35","author":"Sohn","year":"2020","journal-title":"J. Korean Med. Sci."},{"issue":"5","key":"10.1016\/j.thromres.2022.09.025_bb0590","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/s41366-021-00768-8","article-title":"Increased TLR\/MyD88 signaling in patients with obesity: is there a link to COVID-19 disease severity?","volume":"45","author":"Cuevas","year":"2021","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.thromres.2022.09.025_bb0595","series-title":"SARS-CoV-2-associated ssRNAs Activate Inflammation and Immunity via TLR7\/8","author":"Salvi","year":"2021"},{"issue":"16","key":"10.1016\/j.thromres.2022.09.025_bb0600","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022643118","article-title":"SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes","volume":"118","author":"Li","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108628","article-title":"MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells","volume":"34","author":"Yin","year":"2021","journal-title":"Cell Rep."},{"issue":"16","key":"10.1016\/j.thromres.2022.09.025_bb0610","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1089\/ars.2021.0167","article-title":"The MAVS immune recognition pathway in viral infection and sepsis","volume":"35","author":"Sharma","year":"2021","journal-title":"Antioxid. Redox Signal."},{"issue":"7","key":"10.1016\/j.thromres.2022.09.025_bb0615","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/s41422-021-00501-0","article-title":"Publisher correction: SARS-CoV-2 spike protein interacts with and activates TLR4","volume":"31","author":"Zhao","year":"2021","journal-title":"Cell Res."},{"issue":"12","key":"10.1016\/j.thromres.2022.09.025_bb0620","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/01.RES.0000171805.24799.fa","article-title":"Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines","volume":"96","author":"Szotowski","year":"2005","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb0625","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/157340308785160570","article-title":"Roles of IL-6-gp130 signaling in vascular inflammation","volume":"4","author":"Hou","year":"2008","journal-title":"Curr. Cardiol. Rev."},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb0630","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1182\/blood.V74.4.1241.1241","article-title":"Interleukin-6 is a potent thrombopoietic factor in vivo in mice","volume":"74","author":"Ishibashi","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.09.025_bb0635","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1479-5876-3-37","article-title":"Interleukin-1beta induced vascular permeability is dependent on induction of endothelial tissue factor (TF) activity","volume":"3","author":"Puhlmann","year":"2005","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.thromres.2022.09.025_bb0640","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1172\/JCI117202","article-title":"Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system.Effects of thrombin inhibitors","volume":"93","author":"Kirchhofer","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.thromres.2022.09.025_bb0645","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb0650","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1172\/JCI79329","article-title":"Caspase-1-mediated pathway promotes generation of thromboinflammatory microparticles","volume":"125","author":"Rothmeier","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"14","key":"10.1016\/j.thromres.2022.09.025_bb0655","first-page":"1087","article-title":"The role of type 1 interferons in coagulation induced by gram-negative bacteria","volume":"135","author":"Yang","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb0660","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201707","article-title":"Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients","volume":"218","author":"Rodrigues","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.thromres.2022.09.025_bb0665","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3389\/fimmu.2020.01518","article-title":"Targeting the NLRP3 inflammasome in severe COVID-19","volume":"11","author":"Freeman","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0670","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41420-021-00428-w","article-title":"SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes","volume":"7","author":"Ferreira","year":"2021","journal-title":"Cell Death Discov."},{"issue":"6","key":"10.1016\/j.thromres.2022.09.025_bb0675","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.immuni.2019.04.003","article-title":"Inflammasome activation triggers blood clotting and host death through pyroptosis","volume":"50","author":"Wu","year":"2019","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.thromres.2022.09.025_bb0680","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0259061","article-title":"Disulfiram use is associated with lower risk of COVID-19: a retrospective cohort study","volume":"16","author":"Fillmore","year":"2021","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.thromres.2022.09.025_bb0685","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/ATVBAHA.120.314860","article-title":"Endothelial dysfunction and thrombosis in patients with COVID-19-brief report","volume":"40","author":"Nagashima","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb0690","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11239-020-02172-x","article-title":"Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19","volume":"50","author":"Bautista-Vargas","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb0695","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/01.CCM.0000201882.23917.B8","article-title":"Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia\u2013a review","volume":"34","author":"Schultz","year":"2006","journal-title":"Crit. Care Med."},{"issue":"23","key":"10.1016\/j.thromres.2022.09.025_bb0700","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb0705","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jhep.2021.04.050","article-title":"Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy","volume":"75","author":"McConnell","year":"2021","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0710","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12967-020-02573-9","article-title":"Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial","volume":"18","author":"Perrone","year":"2020","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb0715","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.chest.2020.06.006","article-title":"Tocilizumab treatment for cytokine release syndrome in hospitalized patients with coronavirus disease 2019: survival and clinical outcomes","volume":"158","author":"Price","year":"2020","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.thromres.2022.09.025_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102568","article-title":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy","volume":"19","author":"Toniati","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb0725","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/joim.13162","article-title":"Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study","volume":"289","author":"Eimer","year":"2021","journal-title":"J. Intern. Med."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb0730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/annrheumdis-2020-218243","article-title":"Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study","volume":"80","author":"Potere","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0735","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jamainternmed.2020.6252","article-title":"Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19","volume":"181","author":"Gupta","year":"2021","journal-title":"JAMA Intern. Med."},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb0740","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1016\/S2665-9913(21)00012-6","article-title":"Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study","volume":"3","author":"Cavalli","year":"2021","journal-title":"Lancet Rheumatol."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb0745","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5482\/ha-1134","article-title":"Coagulation and inflammation. Molecular insights and diagnostic implications","volume":"31","author":"Lipinski","year":"2011","journal-title":"Hamostaseologie"},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb0750","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/infdis\/jiab044","article-title":"Monocytes and macrophages, targets of SARS-CoV-2: the clue for Covid-19 immunoparalysis","volume":"224","author":"Boumaza","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.thromres.2022.09.025_bb0755","series-title":"Macrophages Govern Antiviral Responses in Human Lung Tissues Protected From SARS-CoV-2 Infection","author":"Kenney","year":"2021"},{"key":"10.1016\/j.thromres.2022.09.025_bb0760","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s41232-020-00146-3","article-title":"How COVID-19 induces cytokine storm with high mortality","volume":"40","author":"Hojyo","year":"2020","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.thromres.2022.09.025_bb0765","first-page":"66","article-title":"Toll-like receptor signaling and regulation of cytokine gene expression in the immune system","author":"Ozato","year":"2002","journal-title":"Biotechniques"},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0770","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ajpath.2020.08.009","article-title":"Immunopathology of hyperinflammation in COVID-19","volume":"191","author":"Gustine","year":"2021","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0775","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"issue":"10223","key":"10.1016\/j.thromres.2022.09.025_bb0780","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan,China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.thromres.2022.09.025_bb0785","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb0790","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1084\/jem.163.3.740","article-title":"Modulation of endothelial cell hemostatic properties by tumor necrosis factor","volume":"163","author":"Nawroth","year":"1986","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.thromres.2022.09.025_bb0795","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1073\/pnas.83.10.3460","article-title":"Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity","volume":"83","author":"Nawroth","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0800","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0014-5793(92)81139-D","article-title":"IL-4 inhibits LPS-, IL-1 beta- and TNF alpha-induced expression of tissue factor in endothelial cells and monocytes","volume":"310","author":"Herbert","year":"1992","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0805","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1182\/blood.V83.1.152.152","article-title":"Effect of human recombinant cytokines on the induction of macrophage procoagulant activity","volume":"83","author":"Schwager","year":"1994","journal-title":"Blood"},{"issue":"45","key":"10.1016\/j.thromres.2022.09.025_bb0810","doi-asserted-by":"crossref","first-page":"28568","DOI":"10.1074\/jbc.272.45.28568","article-title":"Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells","volume":"272","author":"Schecter","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.thromres.2022.09.025_bb0815","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1161\/01.ATV.17.12.3399","article-title":"Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity","volume":"17","author":"Neumann","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2022.09.025_bb0820","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijcard.2016.04.177","article-title":"Expression of functional tissue factor in activated T-lymphocytes in vitro and in vivo: a possible contribution of immunity to thrombosis?","volume":"218","author":"De Palma","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.thromres.2022.09.025_bb0825","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585647","article-title":"Lower circulating interferon-gamma is a risk factor for lung fibrosis in COVID-19 patients","volume":"11","author":"Hu","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb0830","doi-asserted-by":"crossref","first-page":"895","DOI":"10.4049\/jimmunol.155.2.895","article-title":"Thrombin induces IL-6 production in fibroblasts and epithelial cells. Evidence for the involvement of the seven-transmembrane domain (STD) receptor for alpha-thrombin","volume":"155","author":"Sower","year":"1995","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.thromres.2022.09.025_bb0835","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood.V90.9.3595","article-title":"Fibrin regulation of interleukin-8 gene expression in human vascular endothelial cells","volume":"90","author":"Qi","year":"1997","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0840","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1365-2567.1996.d01-635.x","article-title":"Thrombin stimulates production of interleukin-8 in human umbilical vein endothelial cells","volume":"88","author":"Ueno","year":"1996","journal-title":"Immunology"},{"issue":"11","key":"10.1016\/j.thromres.2022.09.025_bb0845","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.4049\/jimmunol.159.11.5620","article-title":"Thrombin activates nuclear factor-kappaB and potentiates endothelial cell activation by TNF","volume":"159","author":"Anrather","year":"1997","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.thromres.2022.09.025_bb0850","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/bph.15587","article-title":"Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019","volume":"179","author":"Subramaniam","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.thromres.2022.09.025_bb0855","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200160","article-title":"Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines","volume":"10","author":"Fara","year":"2020","journal-title":"Open Biol."},{"key":"10.1016\/j.thromres.2022.09.025_bb0860","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","article-title":"The COVID-19 cytokine storm; what we know so far","volume":"11","author":"Ragab","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.thromres.2022.09.025_bb0865","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2020.35.e84","article-title":"Virus isolation from the first patient with SARS-CoV-2 in Korea","volume":"35","author":"Park","year":"2020","journal-title":"J. Korean Med. Sci."},{"issue":"11","key":"10.1016\/j.thromres.2022.09.025_bb0870","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMra1112830","article-title":"The pathogenesis of the antiphospholipid syndrome","volume":"368","author":"Giannakopoulos","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb0875","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/jaut.2000.0409","article-title":"Epidemiology of the antiphospholipid antibody syndrome","volume":"15","author":"Petri","year":"2000","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0880","first-page":"4","article-title":"Prevalence and disease associations of certain autoantibodies in elderly patients","volume":"21","author":"Juby","year":"1998","journal-title":"Clin. Invest. Med."},{"issue":"8","key":"10.1016\/j.thromres.2022.09.025_bb0885","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/CM9.0000000000000705","article-title":"Antiphospholipid syndrome: a clinical perspective","volume":"133","author":"Zuo","year":"2020","journal-title":"Chin. Med. J."},{"issue":"11","key":"10.1016\/j.thromres.2022.09.025_bb0890","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1002\/art.39247","article-title":"Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome","volume":"67","author":"Yalavarthi","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0895","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/107602960601200107","article-title":"Antiphospholipid-mediated thrombosis: interplay between anticardiolipin antibodies and vascular cells","volume":"12","author":"Lopez-Pedrera","year":"2006","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"6","key":"10.1016\/j.thromres.2022.09.025_bb0900","first-page":"1578","article-title":"Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome","volume":"82","author":"Dobado-Berrios","year":"1999","journal-title":"Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2022.09.025_bb0905","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/01.ATV.16.11.1319","article-title":"Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein s","volume":"16","author":"Reverter","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb0910","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/0961203309360810","article-title":"Role of tissue factor in thrombosis in antiphospholipid antibody syndrome","volume":"19","author":"Boles","year":"2010","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb0915","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.revmed.2008.05.020","article-title":"Antiphospholipid antibodies, antiphospholipid syndrome and viral infections","volume":"30","author":"Sene","year":"2009","journal-title":"Rev. Med. Interne"},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb0920","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1053\/sarh.2002.28303","article-title":"Viral infections and antiphospholipid antibodies","volume":"31","author":"Uthman","year":"2002","journal-title":"Semin. Arthritis Rheum."},{"issue":"17","key":"10.1016\/j.thromres.2022.09.025_bb0925","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.thromres.2022.09.025_bb0930","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/ard.62.5.388","article-title":"Antiphospholipid antibodies and infections","volume":"62","author":"Asherson","year":"2003","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb0935","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-0038-1648840","article-title":"Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects","volume":"72","author":"Vila","year":"1994","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.09.025_bb0940","doi-asserted-by":"crossref","DOI":"10.1111\/jth.14893","article-title":"Coagulopathy of COVID-19 and antiphospholipid antibodies","author":"Connell","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.09.025_bb0945","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100610","article-title":"The role of beta-2-glycoprotein I in health and disease associating structure with function: more than just APS","volume":"39","author":"McDonnell","year":"2020","journal-title":"Blood Rev."},{"issue":"5","key":"10.1016\/j.thromres.2022.09.025_bb0950","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/0961203308090025","article-title":"Pathogenic role of antiphospholipid antibodies","volume":"17","author":"Salmon","year":"2008","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.thromres.2022.09.025_bb0955","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3109\/08916934.2013.783025","article-title":"Antiphospholipid antibodies mediate autoimmunity against dying cells","volume":"46","author":"Andreoli","year":"2013","journal-title":"Autoimmunity"},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb0960","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1055\/s-0037-1613033","article-title":"Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies","volume":"87","author":"Espinola","year":"2002","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0965","first-page":"51","article-title":"Effect of anticardiolipin\/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome","volume":"25","author":"Robbins","year":"1998","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0970","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12026-011-8239-5","article-title":"Membrane attack by complement: the assembly and biology of terminal complement complexes","volume":"51","author":"Tegla","year":"2011","journal-title":"Immunol. Res."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0975","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0952-7915(95)80028-X","article-title":"Structure, function and cellular expression of complement anaphylatoxin receptors","volume":"7","author":"Wetsel","year":"1995","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb0980","article-title":"Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots","volume":"5","author":"Tung","year":"2021","journal-title":"Rheumatol. Adv. Pract."},{"issue":"9","key":"10.1016\/j.thromres.2022.09.025_bb0985","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1182\/bloodadvances.2018017095","article-title":"Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies","volume":"2","author":"Muller-Calleja","year":"2018","journal-title":"Blood Adv."},{"issue":"570","key":"10.1016\/j.thromres.2022.09.025_bb0990","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd3876","article-title":"Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19","volume":"12","author":"Zuo","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.thromres.2022.09.025_bb0995","series-title":"Platelet Proteome Analysis Reveals an Early Hyperactive Phenotype in SARS-CoV-2-infected Humanized ACE2 Mice","author":"Subramaniam","year":"2021"},{"key":"10.1016\/j.thromres.2022.09.025_bb1000","first-page":"65","article-title":"Platelets: essential components of the immune system","volume":"16","author":"Ali","year":"2015","journal-title":"Curr. Trends Immunol."},{"issue":"10","key":"10.1016\/j.thromres.2022.09.025_bb1005","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1134\/S0006297920100065","article-title":"NETosis: molecular mechanisms, role in physiology and pathology","volume":"85","author":"Vorobjeva","year":"2020","journal-title":"Biochemistry (Mosc)"},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb1010","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s11239-020-02324-z","article-title":"Neutrophil extracellular traps and thrombosis in COVID-19","volume":"51","author":"Zuo","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb1015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/JLB.3COVCRA0720-359R","article-title":"Neutrophil calprotectin identifies severe pulmonary disease in COVID-19","volume":"109","author":"Shi","year":"2021","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.thromres.2022.09.025_bb1020","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200652","article-title":"Targeting potential drivers of COVID-19: neutrophil extracellular traps","volume":"217","author":"Barnes","year":"2020","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.thromres.2022.09.025_bb1025","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/ATVBAHA.118.311150","article-title":"Neutrophil extracellular traps induce endothelial cell activation and tissue factor production through interleukin-1alpha and cathepsin G","volume":"38","author":"Folco","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.thromres.2022.09.025_bb1030","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1177\/0961203308096662","article-title":"Tissue factor in the antiphospholipid syndrome","volume":"17","author":"Kinev","year":"2008","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.thromres.2022.09.025_bb1035","first-page":"916","article-title":"The role of monocytes in thrombotic disorders. Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms","volume":"102","author":"Shantsila","year":"2009","journal-title":"Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2022.09.025_bb1040","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.4049\/jimmunol.168.8.4209","article-title":"Antiphospholipid antibodies induce monocyte chemoattractant protein-1 in endothelial cells","volume":"168","author":"Cho","year":"2002","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.thromres.2022.09.025_bb1045","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/art.1780400509","article-title":"Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression","volume":"40","author":"Cuadrado","year":"1997","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.thromres.2022.09.025_bb1050","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.imbio.2005.10.009","article-title":"Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway","volume":"210","author":"Yasuda","year":"2005","journal-title":"Immunobiology"},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb1055","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.4049\/jimmunol.1000526","article-title":"TLR2 is one of the endothelial receptors for beta 2-glycoprotein I","volume":"185","author":"Alard","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.thromres.2022.09.025_bb1060","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaut.2014.03.001","article-title":"beta2-glycoprotein I, lipopolysaccharide and endothelial TLR4: three players in the two hit theory for anti-phospholipid-mediated thrombosis","volume":"55","author":"Raschi","year":"2014","journal-title":"J. Autoimmun."},{"issue":"9","key":"10.1016\/j.thromres.2022.09.025_bb1065","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1182\/blood-2002-08-2349","article-title":"Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies","volume":"101","author":"Raschi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.09.025_bb1070","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3389\/fphys.2018.01840","article-title":"Mechanisms of endothelial dysfunction in antiphospholipid syndrome: association with clinical manifestations","volume":"9","author":"Velasquez","year":"2018","journal-title":"Front. Physiol."},{"issue":"5","key":"10.1016\/j.thromres.2022.09.025_bb1075","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/art.21009","article-title":"Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies","volume":"52","author":"Vega-Ostertag","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.thromres.2022.09.025_bb1080","series-title":"Endothelial Cell-activating Antibodies in COVID-19","author":"Shi","year":"2021"},{"key":"10.1016\/j.thromres.2022.09.025_bb1085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.584241","article-title":"Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome","volume":"11","author":"Borghi","year":"2020","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.thromres.2022.09.025_bb1090","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1172\/JCI141374","article-title":"Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis","volume":"130","author":"Skendros","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb1095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00281-011-0290-8","article-title":"Fibrinogen as a key regulator of inflammation in disease","volume":"34","author":"Davalos","year":"2012","journal-title":"Semin. Immunopathol."},{"issue":"6","key":"10.1016\/j.thromres.2022.09.025_bb1100","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s12185-013-1346-4","article-title":"Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry","volume":"97","author":"Lee","year":"2013","journal-title":"Int. J. Hematol."},{"issue":"25","key":"10.1016\/j.thromres.2022.09.025_bb1105","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1182\/blood-2012-09-311381","article-title":"Thrombosis in paroxysmal nocturnal hemoglobinuria","volume":"121","author":"Hill","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb1110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00281-017-0663-8","article-title":"Diseases of complement dysregulation-an overview","volume":"40","author":"Wong","year":"2018","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.thromres.2022.09.025_bb1115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.627579","article-title":"The outcome of critically ill COVID-19 patients is linked to thromboinflammation dominated by the Kallikrein\/Kinin system","volume":"12","author":"Lipcsey","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb1120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41590-021-01114-w","article-title":"Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules","volume":"23","author":"Stravalaci","year":"2022","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb1125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41577-021-00665-1","article-title":"The state of complement in COVID-19","volume":"22","author":"Afzali","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.thromres.2022.09.025_bb1130","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1002\/jmv.27077","article-title":"Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state","volume":"93","author":"Henry","year":"2021","journal-title":"J. Med. Virol."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb1135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1164\/rccm.202005-1926ED","article-title":"Complement activation during critical illness: current findings and an outlook in the era of COVID-19","volume":"202","author":"Bosmann","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"59","key":"10.1016\/j.thromres.2022.09.025_bb1140","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abj1014","article-title":"Complement control for COVID-19","volume":"6","author":"Bosmann","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.thromres.2022.09.025_bb1145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-1-4614-0106-3_9","article-title":"Role of C3, C5 and anaphylatoxin receptors in acute lung injury and in sepsis","volume":"946","author":"Bosmann","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"issue":"9","key":"10.1016\/j.thromres.2022.09.025_bb1150","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1111\/jth.14981","article-title":"COVID-19: a collision of complement, coagulation and inflammatory pathways","volume":"18","author":"Chauhan","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"7836","key":"10.1016\/j.thromres.2022.09.025_bb1155","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41586-020-2600-6","article-title":"Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis","volume":"588","author":"Carvelli","year":"2020","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.thromres.2022.09.025_bb1160","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.4049\/jimmunol.177.7.4794","article-title":"A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways","volume":"177","author":"Ritis","year":"2006","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.thromres.2022.09.025_bb1165","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1182\/blood-2007-01-070631","article-title":"Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury","volume":"110","author":"Redecha","year":"2007","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.thromres.2022.09.025_bb1170","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.116.306853","article-title":"Cross talk pathways between coagulation and inflammation","volume":"118","author":"Foley","year":"2016","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb1175","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaci.2020.05.006","article-title":"Complement activation in patients with COVID-19: a novel therapeutic target","volume":"146","author":"Cugno","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.thromres.2022.09.025_bb1180","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3389\/fphar.2020.00857","article-title":"Combination of ruxolitinib and eculizumab for treatment of severe SARS-CoV-2-related acute respiratory distress syndrome: a controlled study","volume":"11","author":"Giudice","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"59","key":"10.1016\/j.thromres.2022.09.025_bb1185","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abh2259","article-title":"Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection","volume":"6","author":"Ma","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.thromres.2022.09.025_bb1190","series-title":"Highly Pathogenic Coronavirus N Protein Aggravates Lung Injury by MASP-2-mediated Complement Over-activation","author":"Gao","year":"2020"},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb1195","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1055\/s-0038-1655974","article-title":"C5a induces tissue factor activity on endothelial cells","volume":"77","author":"Ikeda","year":"1997","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb1200","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.kint.2020.05.013","article-title":"The case of complement activation in COVID-19 multiorgan impact","volume":"98","author":"Noris","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.thromres.2022.09.025_bb1205","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cytogfr.2020.12.001","article-title":"The roles and potential therapeutic implications of C5a in the pathogenesis of COVID-19-associated coagulopathy","volume":"58","author":"Li","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.thromres.2022.09.025_bb1210","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108555","article-title":"Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19","volume":"219","author":"Laurence","year":"2020","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb1215","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/cei.13523","article-title":"Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage","volume":"202","author":"Amor","year":"2020","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/j.thromres.2022.09.025_bb1220","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/s41591-020-1021-2","article-title":"Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection","volume":"26","author":"Ramlall","year":"2020","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.thromres.2022.09.025_bb1225","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1182\/blood-2012-10-460493","article-title":"Rapid activation of monocyte tissue factor by antithymocyte globulin is dependent on complement and protein disulfide isomerase","volume":"121","author":"Langer","year":"2013","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.thromres.2022.09.025_bb1230","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1182\/blood-2016-11-749879","article-title":"Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development","volume":"129","author":"Subramaniam","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb1235","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"van Niel","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.thromres.2022.09.025_bb1240","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/MOT.0000000000000701","article-title":"Impact of extracellular vesicles on innate immunity","volume":"24","author":"Chen","year":"2019","journal-title":"Curr. Opin. Organ Transpl."},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb1245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18030666","article-title":"Extracellular vesicles deliver host and virus RNA and regulate innate immune response","volume":"18","author":"Kouwaki","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb1250","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/CIRCRESAHA.120.317447","article-title":"The emerging threat of (micro)thrombosis in COVID-19 and its therapeutic implications","volume":"127","author":"McFadyen","year":"2020","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.thromres.2022.09.025_bb1255","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061651","article-title":"COVID-19 related coagulopathy: a distinct entity?","volume":"9","author":"Marchandot","year":"2020","journal-title":"J. Clin. Med."},{"issue":"11","key":"10.1016\/j.thromres.2022.09.025_bb1260","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/CIRCRESAHA.120.317703","article-title":"Platelets can associate with SARS-Cov-2 RNA and are hyperactivated in COVID-19","volume":"127","author":"Zaid","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.thromres.2022.09.025_bb1265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103369","article-title":"Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection","volume":"67","author":"Balbi","year":"2021","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb1270","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/ATVBAHA.120.315547","article-title":"Patients with COVID-19 have elevated levels of circulating extracellular vesicle tissue factor activity that is associated with severity and mortality","volume":"41","author":"Rosell","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2022.09.025_bb1275","article-title":"Longitudinal trend of plasma concentrations of extracellular vesicles in patients hospitalized for COVID-19","volume":"9","author":"Campello","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb1280","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1182\/bloodadvances.2020003308","article-title":"Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19","volume":"5","author":"Guervilly","year":"2021","journal-title":"Blood Adv."},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb1285","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/cmi.2016.1","article-title":"Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia","volume":"13","author":"Yang","year":"2016","journal-title":"Cell Mol. Immunol."},{"issue":"7830","key":"10.1016\/j.thromres.2022.09.025_bb1290","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41586-020-2787-6","article-title":"Animal models for COVID-19","volume":"586","author":"Munoz-Fontela","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb1295","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.jinf.2007.04.351","article-title":"Dengue virus regulates the expression of hemostasis-related molecules in human vein endothelial cells","volume":"55","author":"Jiang","year":"2007","journal-title":"J. Infect."},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb1300","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/jmv.10438","article-title":"Tissue plasminogen activator induced by dengue virus infection of human endothelial cells","volume":"70","author":"Huang","year":"2003","journal-title":"J. Med. Virol."},{"issue":"Suppl 4","key":"10.1016\/j.thromres.2022.09.025_bb1305","doi-asserted-by":"crossref","first-page":"S843","DOI":"10.1093\/clinids\/11.Supplement_4.S843","article-title":"Effect of dengue virus on procoagulant and fibrinolytic activities of monocytes","volume":"11","author":"Krishnamurti","year":"1989","journal-title":"Rev. Infect. Dis."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb1310","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4269\/ajtmh.1989.40.102","article-title":"Stimulation of plasminogen activator inhibitor activity in human monocytes infected with dengue virus","volume":"40","author":"Krishnamurti","year":"1989","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.thromres.2022.09.025_bb1315","article-title":"Vascular leakage in dengue hemorrhagic fever is associated with dengue infected monocytes, monocyte activation\/exhaustion, and cytokines production","volume":"2015","author":"Chunhakan","year":"2015","journal-title":"Int. J. Vasc. Med."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb1320","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.micinf.2016.08.005","article-title":"Increased circulating procoagulant and anticoagulant factors as TF and TFPI according to severity or infecting serotypes in human dengue infection","volume":"19","author":"de Azeredo","year":"2017","journal-title":"Microbes Infect."},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb1325","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/1096-9071(200103)63:3<247::AID-JMV1008>3.0.CO;2-F","article-title":"Activation of coagulation and fibrinolysis during dengue virus infection","volume":"63","author":"Huang","year":"2001","journal-title":"J. Med. Virol."},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb1330","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1160\/TH06-02-0094","article-title":"Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection","volume":"97","author":"Sosothikul","year":"2007","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb1335","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bcmd.2010.08.004","article-title":"Tissue factor expression on monocytes from patients with severe dengue fever","volume":"45","author":"de Azeredo","year":"2010","journal-title":"Blood Cells Mol. Dis."},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb1340","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1055\/s-0038-1651590","article-title":"Herpes simplex virus decreases endothelial cell plasminogen activator inhibitor","volume":"69","author":"Bok","year":"1993","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.09.025_bb1345","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1297-9716-44-16","article-title":"Equine herpesvirus type 1 infection induces procoagulant activity in equine monocytes","volume":"44","author":"Yeo","year":"2013","journal-title":"Vet. Res."},{"issue":"15","key":"10.1016\/j.thromres.2022.09.025_bb1350","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1182\/blood-2011-08-376814","article-title":"Tissue factor and glycoprotein C on herpes simplex virus type 1 are protease-activated receptor 2 cofactors that enhance infection","volume":"119","author":"Sutherland","year":"2012","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.thromres.2022.09.025_bb1355","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13071","article-title":"Anticoagulation increases alveolar hemorrhage in mice infected with influenza A","volume":"4","author":"Tatsumi","year":"2016","journal-title":"Physiol. Rep."},{"issue":"405","key":"10.1016\/j.thromres.2022.09.025_bb1360","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam5441","article-title":"Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy","volume":"9","author":"Schechter","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb1365","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/QAI.0b013e3182910121","article-title":"Circulating levels of tissue factor microparticle procoagulant activity are reduced with antiretroviral therapy and are associated with persistent inflammation and coagulation activation among HIV-positive patients","volume":"63","author":"Baker","year":"2013","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb1370","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/QAI.0b013e3182439355","article-title":"Increased platelet and microparticle activation in HIV infection: upregulation of P-selectin and tissue factor expression","volume":"59","author":"Mayne","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.025_bb1375","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/22221751.2020.1747363","article-title":"Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients","volume":"9","author":"Xiong","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"6","key":"10.1016\/j.thromres.2022.09.025_bb1380","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.thromres.2022.09.025_bb1385","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1165\/rcmb.2020-0453OC","article-title":"Lung epithelial cell transcriptional regulation as a factor in COVID-19-associated coagulopathies","volume":"64","author":"FitzGerald","year":"2021","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"3","key":"10.1016\/j.thromres.2022.09.025_bb1390","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jacbts.2020.12.009","article-title":"Platelet and endothelial activation as potential mechanisms behind the thrombotic complications of COVID-19 patients","volume":"6","author":"Canzano","year":"2021","journal-title":"JACC Basic Transl. Sci."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.025_bb1395","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/ATVBAHA.120.315547","article-title":"Patients with COVID-19 have elevated levels of circulating extracellular vesicle tissue factor activity that is associated with severity and mortality-brief report","volume":"41","author":"Rosell","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.thromres.2022.09.025_bb1400","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12525","article-title":"Comparison of the coagulopathies associated with COVID-19 and sepsis","volume":"5","author":"Campbell","year":"2021","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.09.025_bb1405","article-title":"Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection","volume":"39","author":"Francischetti","year":"2021","journal-title":"EClin. Med."},{"key":"10.1016\/j.thromres.2022.09.025_bb1410","article-title":"Gene expression profiling reveals the shared and distinct transcriptional signatures in human lung epithelial cells infected with SARS-CoV-2, MERS-CoV, or SARS-CoV: potential implications in cardiovascular complications of COVID-19","volume":"7","author":"Jha","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"issue":"16","key":"10.1016\/j.thromres.2022.09.025_bb1415","doi-asserted-by":"crossref","first-page":"8076","DOI":"10.7150\/thno.61810","article-title":"Endothelial cell infection and dysfunction, immune activation in severe COVID-19","volume":"11","author":"Qin","year":"2021","journal-title":"Theranostics"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822004078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822004078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:49:44Z","timestamp":1758736184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384822004078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":283,"alternative-id":["S0049384822004078"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2022.09.025","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tissue factor in COVID-19-associated coagulopathy","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2022.09.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}